▶ 調査レポート

乗り物酔い止め薬の世界市場分析・規模・シェア・成長・動向・予測:薬の種類別(抗コリン薬、抗ヒスタミン薬)、投与経路別(経口、経皮)、販売チャネル別(小売薬局、オンライン薬局)

• 英文タイトル:Motion Sickness Treatment Market (Treatment Type - Anticholinergic, Antihistamines; Route of Administration - Oral, Transdermal; Distribution Channel - Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Transparency Market Researchが調査・発行した産業分析レポートです。乗り物酔い止め薬の世界市場分析・規模・シェア・成長・動向・予測:薬の種類別(抗コリン薬、抗ヒスタミン薬)、投与経路別(経口、経皮)、販売チャネル別(小売薬局、オンライン薬局) / Motion Sickness Treatment Market (Treatment Type - Anticholinergic, Antihistamines; Route of Administration - Oral, Transdermal; Distribution Channel - Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026 / TPM-B06030資料のイメージです。• レポートコード:TPM-B06030
• 出版社/出版日:Transparency Market Research / 2018年5月22日
• レポート形態:英文、PDF、166ページ
• 納品方法:Eメール
• 産業分類:製薬
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Global Site License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、乗り物酔い止め薬の世界市場について調べ、乗り物酔い止め薬の世界規模、市場動向、市場環境、薬の種類別(抗コリン薬、抗ヒスタミン薬)分析、投与経路別(経口、経皮)分析、販売チャネル別(小売薬局、オンライン薬局)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・序文・調査範囲・調査手法
・エグゼクティブサマリー
・乗り物酔い止め薬の世界市場動向
・乗り物酔い止め薬の世界市場環境
・乗り物酔い止め薬の世界市場規模
・乗り物酔い止め薬の世界市場規模:薬の種類別(抗コリン薬、抗ヒスタミン薬)
・乗り物酔い止め薬の世界市場規模:投与経路別(経口、経皮)
・乗り物酔い止め薬の世界市場規模:販売チャネル別(小売薬局、オンライン薬局)
・乗り物酔い止め薬の世界市場:地域別市場規模・分析
・乗り物酔い止め薬の北米市場規模・予測
・乗り物酔い止め薬のアメリカ市場規模・予測
・乗り物酔い止め薬の中南米市場規模・予測
・乗り物酔い止め薬のヨーロッパ市場規模・予測
・乗り物酔い止め薬のアジア市場規模・予測
・乗り物酔い止め薬の日本市場規模・予測
・乗り物酔い止め薬の中国市場規模・予測
・乗り物酔い止め薬のインド市場規模・予測
・乗り物酔い止め薬の中東市場規模・予測
・乗り物酔い止め薬のアフリカ市場規模・予測
・競争状況・関連企業情報

Global Motion Sickness Treatment Market: Overview

Motion sickness is a common condition characterized by a set of symptoms such as dizziness, nausea, and fatigue experienced by a person while traveling. It is caused by difference in impulses received by perceived sense of motion by visual senses and vestibular system’s sense of movement. Conflict among those senses result in motion sickness. Motion sickness is estimated to be experienced by around 50% travelers; it is most widely witnessed among children and elderly people. Various prescription and OTC drugs and products are used to treat motion sickness and provide relief from its symptoms. Anticholinergic, antihistamines, and sympathomimetic are the most commonly used medications, while traditional remedies such as herbal medicines, homeopathic medicines, and others are also available as OTC products for treatment of motion sickness.

The global motion sickness treatment market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on treatment type, route of administration, distribution channel, and region. A detailed qualitative analysis of drivers and restraints of the market has been provided in the overview section. The report provides key insights of the global motion sickness treatment market comprising global pipeline analysis, key mergers and acquisitions, OTC vs. prescription drug market assessment, and Porter’s Five Forces Analysis. Additionally, the competition landscape section comprises competitive matrix, key player’s market footprint by treatment type and region, key competitive business strategies, and company profiles with business overview to understand the competitive landscape in the market. The report also provides market attractiveness analysis by region, thereby presenting a thorough analysis of the overall competitive scenario in the global motion sickness treatment market.

Global Motion Sickness Treatment Market: Key Segments

Based on treatment type, the global motion sickness treatment market has been segmented into anticholinergic, antihistamines, and others. The report also offers overview of the global motion sickness treatment market based on oral, transdermal, and other routes of administration. The treatment type segments have been analyzed based on commercially available motion sickness treatment drug and product types, route of administration, and adoption of each treatment type. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

In terms of distribution channel, the global motion sickness treatment market has been segmented into retail pharmacies, online pharmacies, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Motion Sickness Treatment Market: Regional Outlook

Geographically, the global motion sickness treatment market has been segmented into five major regions and the key countries/sub-regions in the respective region: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the motion sickness treatment market are GlaxoSmithKline plc, Perrigo Company plc, Prestige Brands, Inc., WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals, Inc., Myungmoon Pharm Co., Ltd., Baxter International, Inc. and Reliefband Technologies LLC.

The global motion sickness treatment market has been segmented as follows:

Global Motion Sickness Treatment Market, by Treatment Type

Anticholinergic
Antihistamines
Others (sympathomimetic, traditional medicines, wearable relief bands, etc.)
Global Motion Sickness Treatment Market, by Route of Administration

Oral
Transdermal
Others
Global Motion Sickness Treatment Market, by Distribution Channel

Retail Pharmacies
Online Pharmacies
Others (drug stores and hospital pharmacies)
Global Motion Sickness Treatment Market, by Region

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Motion Sickness Treatment Market

4. Market Overview
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.1. Restraints
4.3. Global Motion Sickness Treatment Market Analysis and Forecast, 2016–2026
4.3.1. Market Revenue Projections (US$ Mn)
4.4. Porter’s Five Force Analysis

5. Market Outlook
5.1.Pipeline Analysis
5.2.Key Mergers & Acquisitions
5.3.OTC & Prescription Market Analysis

6. Global Motion Sickness Treatment Market Analysis and Forecasts, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Treatment Type, 2016–2026
6.3.1. Anticholinergic
6.3.2. Antihistamines
6.3.3. Others
6.4. Market Attractiveness, by Treatment Type

7. Global Motion Sickness Treatment Market Analysis and Forecasts, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Route of Administration, 2016–2026
7.3.1. Oral
7.3.2. Transdermal
7.3.3. Others
7.4. Market Attractiveness, by Route of Administration

8. Global Motion Sickness Treatment Market Analysis and Forecasts, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Distribution Channel, 2016–2026
8.3.1. Retail Pharmacies
8.3.2. Online Pharmacies
8.3.3. Others
8.4. Market Attractiveness, by Distribution Channel

9. Global Motion Sickness Treatment Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region

10. North America Motion Sickness Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Treatment Type, 2016–2026
10.2.1. Anticholinergic
10.2.2. Antihistamines
10.2.3. Others
10.3. Market Value Forecast, by Route of Administration, 2016–2026
10.3.1. Oral
10.3.2. Transdermal
10.3.3. Others
10.4. Market Value Forecast, by Distribution Channel, 2016–2026
10.4.1. Retail Pharmacies
10.4.2. Online Pharmacies
10.4.3. Others
10.5. Market Value Forecast, by Country, 2016–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Treatment Type
10.6.2. By Route of Administration
10.6.3. By Distribution Channel
10.6.4. By Country

11. Europe Motion Sickness Treatment Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Treatment Type, 2016–2026
11.2.1. Anticholinergic
11.2.2. Antihistamines
11.2.3. Others
11.3.Market Value Forecast, by Route of Administration, 2016–2026
11.3.1. Oral
11.3.2. Transdermal
11.3.3. Others
11.4.Market Value Forecast, by Distribution Channel, 2016–2026
11.4.1. Retail Pharmacies
11.4.2. Online Pharmacies
11.4.3. Others
11.5.Market Value Forecast, by Country / Sub-region, 2016–2026
11.5.1. Germany
11.5.2. France
11.5.3. U.K.
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6.Market Attractiveness Analysis
11.6.1. By Treatment Type
11.6.2. By Route of Administration
11.6.3. By Distribution Channel
11.6.4. By Country / Sub-region

12. Asia Pacific Motion Sickness Treatment Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Treatment Type, 2016–2026
12.2.1. Anticholinergic
12.2.2. Antihistamines
12.2.3. Others
12.3.Market Value Forecast, by Route of Administration, 2016–2026
12.3.1. Oral
12.3.2. Transdermal
12.3.3. Others
12.4.Market Value Forecast, by Distribution Channel, 2016–2026
12.4.1. Retail Pharmacies
12.4.2. Online Pharmacies
12.4.3. Others
12.5.Market Value Forecast, by Country / Sub-region, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6.Market Attractiveness Analysis
12.6.1. By Treatment Type
12.6.2. By Route of Administration
12.6.3. By Distribution Channel
12.6.4. By Country / Sub-region

13. Latin America Motion Sickness Treatment Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by Treatment Type, 2016–2026
13.2.1. Anticholinergic
13.2.2. Antihistamines
13.2.3. Others
13.3.Market Value Forecast, by Route of Administration, 2016–2026
13.3.1. Oral
13.3.2. Transdermal
13.3.3. Others
13.4.Market Value Forecast, by Distribution Channel, 2016–2026
13.4.1. Retail Pharmacies
13.4.2. Online Pharmacies
13.4.3. Others
13.5.Market Value Forecast, by Country, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6.Market Attractiveness Analysis
13.6.1. By Treatment Type
13.6.2. By Route of Administration
13.6.3. By Distribution Channel
13.6.4. By Country / Sub-region

14. Middle East & Africa Motion Sickness Treatment Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2.Market Value Forecast, by Treatment Type, 2016–2026
14.2.1. Anticholinergic
14.2.2. Antihistamines
14.2.3. Others
14.3.Market Value Forecast, by Route of Administration, 2016–2026
14.3.1. Oral
14.3.2. Transdermal
14.3.3. Others
14.4.Market Value Forecast, by Distribution Channel, 2016–2026
14.4.1. Retail Pharmacies
14.4.2. Online Pharmacies
14.4.3. Others
14.5.Market Value Forecast, by Country / Sub-region, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6.Market Attractiveness Analysis
14.6.1. By Treatment Type
14.6.2. By Route of Administration
14.6.3. By Distribution Channel
14.6.4. By Country / Sub-region

15. Competition Landscape
15.1.Market Player – Competition Matrix (By Tier and Size of companies)
15.2.Market Footprint Analysis
15.2.1. By Region
15.2.2. By Treatment Type
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. GlaxoSmithKline plc
15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.1.2.Product Portfolio
15.4.1.3.Financial Overview
15.4.1.4.SWOT Analysis
15.4.1.5.Strategic Overview
15.4.2. Perrigo Company plc
15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.2.2.Product Portfolio
15.4.2.3.Financial Overview
15.4.2.4.SWOT Analysis
15.4.2.5.Strategic Overview
15.4.3. Prestige Brands, Inc.
15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.3.2.Product Portfolio
15.4.3.3.Financial Overview
15.4.3.4.SWOT Analysis
15.4.3.5.Strategic Overview
15.4.4. Wellspring Pharmaceutical Corporation
15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.4.2.Product Portfolio
15.4.4.3.SWOT Analysis
15.4.4.4.Strategic Overview
15.4.5. Caleb Pharmaceuticals, Inc.
15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.5.2.Product Portfolio
15.4.5.3.SWOT Analysis
15.4.5.4.Strategic Overview
15.4.6. Myungmoon Pharm CO., LTD.
15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.6.2.Product Portfolio
15.4.6.3.Financial Overview
15.4.6.4.SWOT Analysis
15.4.6.5.Strategic Overview
15.4.7. Baxter International Inc.
15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.7.2.Product Portfolio
15.4.7.3.Financial Overview
15.4.7.4.SWOT Analysis
15.4.7.5.Strategic Overview
15.4.8. Reliefband Technologies LLC
15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.8.2.Product Portfolio
15.4.8.3.Financial Overview
15.4.8.4.SWOT Analysis
15.4.8.5.Strategic Overview

List of Tables

Table 01: Pipeline Analysis (1/2)
Table 02: Pipeline Analysis (2/2)
Table 03: Key Mergers and Acquisitions Snapshot (1/2)
Table 04: Key Mergers and Acquisitions Snapshot (2/2)
Table 05: Global Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 06: Global Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 07: Global Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 08: Global Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 09: North America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 10: North America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 11: North America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 12: North America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 13: Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 14: Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 15: Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 16: Europe Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 17: Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 18: Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 19: Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 20: Asia Pacific Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 21: Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 22: Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 23: Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 24: Latin America Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country / Sub-region, 2016–2026
Table 25: Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 26: Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 27: Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 28: Middle East & Africa Motion Sickness Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 29: Key Players Market Footprint Analysis, by Treatment Type
Table 30: Key Players Market Footprint Analysis, by Region